𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma : Are response evaluation criteria in solid tumors reliable?

✍ Scribed by Alejandro Forner; Carmen Ayuso; María Varela; Jordi Rimola; Amelia J. Hessheimer; Carlos Rodriguez de Lope; María Reig; Luís Bianchi; Josep M. Llovet; Jordi Bruix

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
135 KB
Volume
115
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of tumor response by Response
Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma
✍ Julien Edeline; Eveline Boucher; Yan Rolland; Elodie Vauléon; Marc Pracht; Chris 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 578 KB

## Abstract ## BACKGROUND: A significant improvement in overall survival (OS) was demonstrated in patients with advanced hepatocellular carcinoma (HCC) who received sorafenib (Sor) in the Sorafenib HCC Assessment Randomized Protocol (SHARP) study, in contrast to a response rate (RR) of 2% assessed

Evaluation of cellular uptake, tumor ret
Evaluation of cellular uptake, tumor retention, radiation response, and tumor pathophysiology in experimental solid tumors after an intratumoral infusion of colloidal 32P
✍ Intae Lee; Paul E. Wallner 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 1 views

## BACKGROUND. Order et al. successfully deposited ú 85% of radionuclides in pan- Intae Lee, Ph.D. creatic carcinoma patients using an intratumoral (i t) infusion of macroaggregated

MRI evaluation of pathologically complet
MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy
✍ Jeon Hor Chen; Byon Feig; Garima Agrawal; Hon Yu; Philip M. Carpenter; Rita S. M 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB 👁 2 views

## Abstract ## BACKGROUND. This study investigated the role of magnetic resonance imaging (MRI) in evaluation of pathologically complete response and residual tumors in patients who were receiving neoadjuvant chemotherapy (NAC) for both positive and negative HER‐2 breast cancer. ## METHODS. Fift